Pacifica Partners’s VanEck Biotech ETF BBH Stock Holding History

Pacifica Partners’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.28K	Hold	25	–	–	﹤0.01%	343
2026 Q1	$4.7K	Hold	25	–	–	﹤0.01%	359
2025 Q4	$4.76K	Hold	25	–	–	﹤0.01%	341
2025 Q3	$4.3K	Hold	25	–	–	﹤0.01%	399
2025 Q2	$3.82K	Hold	25	–	–	﹤0.01%	413
2025 Q1	$3.85K	Hold	25	–	–	﹤0.01%	401
2024 Q4	$3.92K	Hold	25	–	–	﹤0.01%	391
2024 Q3	$4.43K	Hold	25	–	–	﹤0.01%	406
2024 Q2	$4.18K	Hold	25	–	–	﹤0.01%	426
2024 Q1	$4.13K	Hold	25	–	–	﹤0.01%	422
2023 Q4	$3.83K	Hold	25	–	–	﹤0.01%	447
2023 Q3	$3.87K	Hold	25	–	–	﹤0.01%	431
2023 Q2	$3.91K	Hold	25	–	–	﹤0.01%	392
2023 Q1	$4.11K	Hold	25	–	–	﹤0.01%	402
2022 Q4	$3.97K	Hold	25	–	–	﹤0.01%	371
2022 Q3	$4K	Hold	25	–	–	﹤0.01%	377
2022 Q2	$4K	Hold	25	–	–	﹤0.01%	382
2022 Q1	$4K	Hold	25	–	–	﹤0.01%	383
2021 Q4	$4K	Hold	25	–	–	﹤0.01%	377
2021 Q3	$5K	Hold	25	–	–	﹤0.01%	353
2021 Q2	$5K	Buy	+25	New	+$4.65K	﹤0.01%	347

Other funds holding BBH

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

HFAS

Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return

VIP

Value Investment Professionals New York $119M AUM

PAW

Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

FFN

Focus Financial Network Minneapolis, Minnesota $3.23B AUM 29.61% 1-Year Est. Return

HWM

Howard Wealth Management Madison, Connecticut $270M AUM 19.06% 1-Year Est. Return

Pacifica Partners's BBH Position: Q2 2026 in Review

Pacifica Partners held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 25 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Pacifica Partners first reported a position in BBH in Q2 2021 and has held it in 21 quarters since. 20 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Pacifica Partners held 25 shares of VanEck Biotech ETF worth $5.28K as of Q2 2026.
Pacifica Partners left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #343 holding.
Pacifica Partners first reported a position in VanEck Biotech ETF in Q2 2021 and has held it in 21 quarters since.
20 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.